Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Nick who wrote (479)	1/20/1998 12:50:00 PM
From: John Hauser	Respond to of 1580

Greeting from a first time poste to this thread, Just wanted to say hi and that I swapped some Dell profits into some MRK @87 in early Nov. and am enjoying the ride so far. Those PC stocks can drive you crazy and I was looking for a little "safe shelter" from the volatility. I think MRK will treat all long-term holders well. Good luck to all, JH

To: Nick who wrote (479)	1/20/1998 2:40:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 1580

Mariola Hagger was just on CNBC. MRK is her #1 pick and Deutche Morgan Grenfel just put them on their US Focus list. The AHP/SBH merger has been discussed on CNBC all day today. They have had Kevin Wilson and Arvind Desai on, and David Favor and Joe Kernan have done reports on the merge and the entire sector. I have put synopsis of the reports on Links to Ligand: home.att.net as well as Financial Times and WSJ reports. They are under the SBH and AHP Alliances.